Jim M Olson

16PUBLICATIONS
188CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomaterialsMicrofluidics and nanofluidicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jan 21, 2026
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma.

Emma D Wrenn, Jacob C Harris, April A Apfelbaum

|Aug 27, 2025
PhoCoil: A photodegradable and injectable single-component recombinant protein hydrogel for minimally invasive delivery and degradation.

Nicole E Gregorio, Fan Zhang, Yusuke Suita

|Nov 18, 2024
Versatile tissue-injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics.

Eric S Nealy, Steven J Reed, Steven M Adelmund

|Oct 09, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect.

Zachary R Crook, Gregory P Sevilla, Pamela Young

|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapy.

Sylvain Simon, Grace Bugos, Rachel Prins

Pageof 3

Frequent Collaborators

5 joint publications

Stefan M Pfister

4 joint publications

Marco A Marra

4 joint publications

Steven J M Jones

4 joint publications

Hiromichi Suzuki